Targeting liver may have an impact on glycaemia?
Thursday, 19 September 2019, 08:30 - 10:00, Serrano-Rios Hall
Chair: H. Al-Hasani, DE; K. Bouzakri, FR
H. Katagiri, JP: Regulation of beta cell function by the liver: nerve implication
K. Sakamoto, CH: AMP-regulated and AMPK-related enzymes as drug target in the liver?
G.I. Shulman, US: Are liver-targeting drugs needed in the treatment of diabetes?